Abstract

A preliminary structure–activity relationship study revealed the potential ST3 oligosaccharide antigenic epitope for anti-ST3 vaccine development.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call